Sunhawk Vision Biotech (ROCO:7759) Revenue: NT$0.00 Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:7759 Sunhawk Vision Biotech Inc ROCO:7759
20 GF Score
Price NT$30.30
! 1 Warning Sign
View Full Analysis

What is Sunhawk Vision Biotech Revenue?

Sunhawk Vision Biotech ROCO:7759 20 Revenue is NT$0.00 Mil as of Jun. 2026. GuruFocus rates ROCO:7759 with a GF Score™ of 20/100. The stock has 1 warning sign investors should review.

Sunhawk Vision Biotech's revenue for the six months ended in Jun. 2026 was NT$0.00 Mil. Its revenue for the trailing twelve months (TTM) ended in Jun. 2026 was NT$0.00 Mil. Sunhawk Vision Biotech's Revenue per Share for the six months ended in Jun. 2026 was NT$0.00. Its Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2026 was NT$0.00.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.


Sunhawk Vision Biotech  (ROCO:7759) Revenue Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:


Slow Grower: Inflation < 10-Year Revenue Growth Rate < 10%:
Stalwart: 10% < 10-Year Revenue Growth Rate < 20%:
Fast Grower: 10-Year Revenue Growth Rate > 20%:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.


Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.


Sunhawk Vision Biotech Revenue Related Terms


Sunhawk Vision Biotech Revenue Historical Data

* Premium members only.

The historical data trend for Sunhawk Vision Biotech's Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sunhawk Vision Biotech Revenue Chart

Sunhawk Vision Biotech Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Revenue
Get a 7-Day Free Trial 0.95 0.00 0.00 0.00 0.00

Sunhawk Vision Biotech Semi-Annual Data
Dec20 Dec21 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

ROCO:7759 vs VRTX, REGN, MRNA: Revenue Comparison

For the Biotechnology subindustry, Sunhawk Vision Biotech's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sunhawk Vision Biotech Revenue vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Sunhawk Vision Biotech's Revenue distribution charts can be found below:

* The bar in red indicates where Sunhawk Vision Biotech's Revenue falls into.


ROCO:7759
20GF Score
Sunhawk Vision Biotech Inc ROCO:7759
Revenue is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sunhawk Vision Biotech Revenue Calculation

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

Revenue for the trailing twelve months (TTM) ended in Jun. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was NT$0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Revenue →
What does a Revenue of NT$0.00 Mil mean?
Sunhawk Vision Biotech (ROCO:7759) has a Revenue of NT$0.00 Mil as of Jun. 2026. Revenue is the total amount a company generates as sales through its operations. View historical data on Sunhawk Vision Biotech and its competitors.
Is Sunhawk Vision Biotech's Revenue too high?
Sunhawk Vision Biotech's current Revenue is NT$0.00 Mil. Overall, Sunhawk Vision Biotech has a GF Score™ of 20/100, reflecting its overall financial health beyond just this single metric.
How does Sunhawk Vision Biotech's Revenue compare to VRTX and REGN?
Sunhawk Vision Biotech's Revenue of NT$0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Revenue for a Biotechnology company?
A good Revenue depends on the Biotechnology industry context. However, Revenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Revenue mean?
A high Revenue can signal that a stock is expensive relative to its fundamentals. Revenue is the total amount a company generates as sales through its operations. View historical data on Sunhawk Vision Biotech and its competitors. Sunhawk Vision Biotech's current Revenue is NT$0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sunhawk Vision Biotech stock overvalued right now?
Sunhawk Vision Biotech (ROCO:7759) has a current Revenue of NT$0.00 Mil. The current Revenue is NT$0.00 Mil. Sunhawk Vision Biotech's overall GF Score™ is 20/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Revenue calculated?
Revenue is calculated from a company's financial statements. For Sunhawk Vision Biotech (ROCO:7759), the current Revenue is NT$0.00 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Sunhawk Vision Biotech Business Description

Address No. 6 Siwei 3rd Road, 17th Floor, Room A1, Lingya District, Kaohsiung, TWN
Sunhawk Vision Biotech Inc is a biotechnology company. The company is focused on developing new solutions for eye health and vision care. The company specializes in research and development of cutting-edge technologies aimed at treating and preventing ocular diseases. Their product portfolio includes products and services for curing dry eyes, myopia, and corneal erosion.
20GF Score

Get the complete analysis for ROCO:7759

Revenue is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$30.30
Price